
When you join NOS as a Corporate Member you will be helping NOS reach our goals and objectives! The benefits to your organization include:
- Increased awareness of your products and services;
- Gain recognition in the oncology marketplace;
- Communicate to key audience of cancer care professionals who make purchasing decisions for their practice;
- Establish an ongoing, brand-building relationship with physicians and their practices
We offer Gold and Platinum Corporate membership levels. For information about our corporate membership, please click here.
To obtain your corporate membership application form, click here, or contact Natalie Mandolfo.....your support is essential to our success!
Platinum member Amgen has released information on new drug indication for Prolia (denosumab). Please click on the following links for the PI for Prolia and the Dear Doctor letter that corresponds to it
prolia_piA[1].pdf
Dear_Doctor_E[2].docx
Other NEW drugs recently released from Genentech/Roche -- Zelboraf
Pfizer -- Xalcori
Celgene --- ISTODAX - please see the link for a letter for state societies IST11018_PTCL_.pdf
7/14/11